In the latest achievement for QuantWave's forecasting platform, the stock of PFIZER INC. successfully reached the price target as predicted....
Pfizer Inc. stock recently hit the price target forecast by QuantWave, resulting in a profit of 6.03%. The forecast signal was generated on June 18, 2025, with a price of $23....
On June 20, 2025, QuantWave forecasted a long signal for PFIZER INC., with a price of 23.97 $. The target price of 25.32 $ was reached on July 2, 2025, resulting in a profit of 5.63%....
On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.42. Fast forward to July 2, 2025, PFIZER INC....
On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at 23.75 $....
On May 28, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC.'s stock when it was priced at 23.18 $....
PFIZER INC. has successfully reached the price target forecast set by QuantWave, signaling a profitable long position. The forecast signal was issued on 2025-05-21 when the stock was at 23.04 $....
Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
QuantWave's forecast for PFIZER INC. proved to be successful as the stock reached the predicted target price of 23.84 $ on April 3, 2025, from the initial signal date of May 7, 2024, when the price was at 25....
According to the latest news, Artisan Global Opportunities Fund has reduced its stake in Novo Nordisk AS (NVO). This move comes as the fund's management evaluates its portfolio and makes necessary adjustments....
QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved to be highly accurate, as the stock reached the predicted target price of 1172.09 $ on August 15, 2024, from the signal price of 991....
On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....
QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....
QuantWave, an automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with the successful achievement of a price target forecast for Bristol-Myers Squibb Company. The forecast, which signaled a short direction on January 23, 2025, when the stock was priced at 57.74 USD, saw the target price of 52.63 USD reached on February 14, 2025, resulting in a prof...